On Wednesday, Symbiotic – the collateral markets platform backed by Paradigm, Pantera Capital, cyber•Fund and Coinbase Ventures – announced the integration of Symbiotic Liquid Lane, an instant USDC liquidity facility, with Centrifuge, the leading tokenization and onchain asset management platform.
Symbiotic brings instant liquidity to tokenized funds
The newly-unveiled integration supports tokenized funds issued through Centrifuge: JAAA, Janus Henderson’s AAA-rated CLO strategy, HYB, New York Life Investment Management’s tokenized U.S. high-yield bond strategy, and JTRSY, Janus Henderson’s short duration treasury strategy.
This covers Centrifuge’s $1.6B AUM. Symbiotic Liquid Lane offers eligible holders immediate access to USDC redemptions, accelerating JAAA and JTRSY from T+1 and HYB from T+3–T+5.
Instead of locking capital into product-specific pools, Liquid Lane allows the same shared capital base to support multiple tokenized funds. The capital can remain productively deployed across approved on-chain lending markets between transactions and be recalled as liquidity demand arises, making the model more capital-efficient and scalable across issuers and asset classes.
As tokenized markets come of age, the infrastructure around issued assets is expanding to support more ways for investors to hold, exchange, finance, and deploy them.
By extending one shared liquidity layer across short-term U.S. Treasuries, AAA-rated CLOs, and U.S. high-yield corporate bonds, Symbiotic and Centrifuge are demonstrating how tokenized funds can become more flexible across on-chain markets, supporting broader institutional use and adoption. Commenting, Misha Putiatin, co-founder of Symbiotic, said:
“Existing liquidity models dedicate capital to product-specific pools, while Symbiotic Liquid Lane allows the same capital base to support a range of RWAs and earn through multiple strategies between settlement events. By bringing instant liquidity to a portfolio of this scale, spanning institutional managers and asset classes, Symbiotic and Centrifuge are moving beyond bespoke, fund-by-fund solutions toward a scalable model that can make immediate exits a standard feature of tokenized markets.”
Resolving the liquidity bottleneck
Although tokenized assets are increasingly moving into institutional markets, liquidity remains a major constraint on their broader use. Redemption periods for some private-credit and structured products can extend to 90 days, contributing to low capital utilization.
BitMart research found that less than 10 percent of tokenized RWA value is actively deployed across DeFi lending and collateral markets. Centrifuge’s 2026 Tokenization Outlook reinforces the importance of solving this gap: 67 percent of surveyed industry operators identified reliable liquidity and redemption as the most important factor in building confidence among end investors.
By giving eligible holders immediate access to USDC while the underlying redemption continues in parallel, Liquid Lane makes tokenized funds easier to finance, pledge, and redeploy across on-chain markets. Bhaji Illuminati, CEO, Centrifuge, said:
“Centrifuge has long focused on bringing real-world assets on-chain, and our partnership with Symbiotic brings instant liquidity to those assets. Giving investors confidence in the asset and its exit path through reliable redemption infrastructure is critical to scaling tokenized markets. Symbiotic helps solve a key bottleneck for RWAs, making tokenized assets easier to hold, distribute, and use across on-chain markets.”
